Chronic Inflammatory Demyelinating Polyneuropathy - 26 Studies Found

Completed : Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
:
  • Demyelinating Diseases
  • Paraproteinemias

: 1999-11-03
: Drug: intravenous immunoglobulin (IVIg)
Completed : Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
: 2005-09-13
:
  • Drug: Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified

Terminated : Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP
: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
: 2010-10-06
:
  • Drug: NewGam 10% Loading dose

Withdrawn : Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)
: Chronic Inflammatory Demyelinating Neuropathy
: 2012-12-06
: Drug: Alemtuzumab infusion
Recruiting : Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
: CIDP
: 2015-12-10
: Other: CIDP treated (IVIG) usual treatment with intravenous immunoglobulin
RECRUITING : Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
: 2024-11-21
: PANZYGA is a human immunoglobin solution with 10% protein content for intravenous (IV) administration.
<<< Previous